Your browser doesn't support javascript.
loading
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival.
Llovet, Josep M; Montal, Robert; Villanueva, Augusto.
Afiliación
  • Llovet JM; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Catalonia, Spain; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. Electronic address: jmllovet@clinic.cat.
  • Montal R; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.
  • Villanueva A; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J Hepatol ; 70(6): 1262-1277, 2019 06.
Article en En | MEDLINE | ID: mdl-30943423

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article